These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7484198)

  • 1. Cost-effectiveness of clozapine treatment in therapy-refractory schizophrenia.
    Jonsson D; Wålinder J
    Acta Psychiatr Scand; 1995 Sep; 92(3):199-201. PubMed ID: 7484198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Grabowski J; Douyon R; Thomas J; Henderson W; Charney D
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1237-61. PubMed ID: 9865219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.
    Meltzer HY; Cola P; Way L; Thompson PA; Bastani B; Davies MA; Snitz B
    Am J Psychiatry; 1993 Nov; 150(11):1630-8. PubMed ID: 8105705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics].
    Geronimi-Ferret D; Lesay M; Barges-Bertocchio MH; Cornet-Bonnefont M; Robert H
    Encephale; 1997 Sep; 23 Spec No 4():24-31. PubMed ID: 9417402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D
    N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New vs. old antipsychotics: the Texas experience.
    Reid WH
    J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Allan E; Erdos J; Frisman LK; Xu W; Thomas J; Henderson W; Charney D
    Arch Gen Psychiatry; 1999 Jun; 56(6):565-72. PubMed ID: 10359474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
    Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW
    Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
    Kilian R; Angermeyer MC
    Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
    Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
    Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study.
    Hayhurst KP; Brown P; Lewis SW
    J Psychopharmacol; 2002 Jun; 16(2):169-75. PubMed ID: 12095076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients.
    Revicki DA; Luce BR; Weschler JM; Brown RE; Adler MA
    Hosp Community Psychiatry; 1990 Aug; 41(8):850-4. PubMed ID: 2169457
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical economic impact of schizophrenia].
    Martin P
    Encephale; 1995 Jun; 21 Spec No 3():67-73. PubMed ID: 7628346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of monitoring clozapine.
    Eilers R
    Hosp Community Psychiatry; 1991 Sep; 42(9):955-6. PubMed ID: 1743673
    [No Abstract]   [Full Text] [Related]  

  • 15. [Leponex: experience of the hospital pharmacist].
    Gury C; Dechelette N; Gayral P
    Encephale; 1995 Jun; 21 Spec No 3():61-5. PubMed ID: 7628345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals.
    Essock SM; Frisman LK; Covell NH; Hargreaves WA
    Arch Gen Psychiatry; 2000 Oct; 57(10):987-94. PubMed ID: 11015817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of clozapine prescription on inpatient resource utilization.
    Sernyak MJ; Rosenheck R; Desai R; Stolar M; Ripper G
    J Nerv Ment Dis; 2001 Nov; 189(11):766-73. PubMed ID: 11758660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient response and resource management: another view of clozapine treatment of schizophrenia.
    Carpenter WT; Conley RR; Buchanan RW; Breier A; Tamminga CA
    Am J Psychiatry; 1995 Jun; 152(6):827-32. PubMed ID: 7755110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine: progress in treating refractory schizophrenia.
    Hirsch SR; Puri BK
    BMJ; 1993 May; 306(6890):1427-8. PubMed ID: 8518636
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimating clozapine's cost to the nation.
    Terkelsen KG; Grosser RC
    Hosp Community Psychiatry; 1990 Aug; 41(8):863-9. PubMed ID: 2169458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.